| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 06/02/2005 | US20050119204 Osteopontin-related compositions and methods |
| 06/02/2005 | US20050118715 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 06/02/2005 | US20050118271 Polytartrate composition |
| 06/02/2005 | US20050118244 penetration promoter; hormone replacement therapy; contraception |
| 06/02/2005 | US20050118242 Using testosterone; topical applying to skins |
| 06/02/2005 | CA2544230A1 Combinations of at1-antagonists, amiloride or triamterine, and a diuretic |
| 06/01/2005 | EP1535915A1 Furan or thiophene derivative and medicinal use thereof |
| 06/01/2005 | EP1534703A2 Antagonists of melanin concentrating hormone receptor |
| 06/01/2005 | EP1534687A1 Pyrimidine compounds |
| 06/01/2005 | EP1534668A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 06/01/2005 | EP1534663A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 06/01/2005 | EP1534512A1 Coated particles, methods of making and using |
| 06/01/2005 | EP1534389A2 Pyrazolopyrimidines as kinase inhibitors |
| 06/01/2005 | EP1534321A1 Methods of use of compounds with preptin function |
| 06/01/2005 | EP1534289A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 06/01/2005 | EP1534250A2 Electrospun amorphous pharmaceutical compositions |
| 06/01/2005 | EP1453820B1 Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents |
| 06/01/2005 | EP1176880B1 Supplement for restoring growth hormone levels |
| 06/01/2005 | EP1148871B1 Core tablet for controlled release of gliclazide after oral administration |
| 06/01/2005 | EP1131061B1 Agent for lowering prolactin |
| 06/01/2005 | EP1100878B1 Process for producing genetically modified cd34-negative adherently growing haematopoietic stem cells |
| 06/01/2005 | EP1062210B1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 06/01/2005 | EP1003744B1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS |
| 06/01/2005 | CN1622822A Medicinal compositions containing ghrelin |
| 05/31/2005 | US6900344 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 05/31/2005 | US6900318 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 05/31/2005 | US6900205 Antidiabetic agents |
| 05/31/2005 | US6900055 Oxygen permeable biocompatible elastomer for propagating viable tissue; tissue engineering |
| 05/31/2005 | US6900051 Generating insulin secreting cells; obtain mammalian pancreatic tissues, dissociate cells, dedifferentiate into insulin precursor cells, isolate and propagate cells |
| 05/31/2005 | US6899890 Bioadhesive drug delivery system |
| 05/31/2005 | US6899888 Suppressing bone disordes such as decalcification or fractures in humans having prostate gland cancers by administering antiestrogen selected from triphenylethylene or toremifene; hormone inhibitors |
| 05/31/2005 | US6899867 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 05/31/2005 | US6899700 Therapeutic agent delivery tampon |
| 05/26/2005 | WO2005028438A9 Novel piperidine derivative |
| 05/26/2005 | US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 05/26/2005 | US20050113353 Applying gel containing testosterone |
| 05/26/2005 | US20050113299 Protein a compositions and methods of use |
| 05/26/2005 | US20050112725 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/26/2005 | US20050112721 Chimeric peptide immunogens |
| 05/26/2005 | US20050112570 Indicator for development of diabetes |
| 05/26/2005 | US20050112565 Proteases |
| 05/26/2005 | US20050112206 Mixture of drug, aminoacrylate polymer and acid |
| 05/26/2005 | US20050112181 By transdermal administration of testosterone in a hydroalcoholic gel; unique pharmacokinetic steady-state profile |
| 05/26/2005 | US20050112092 Stable, aerosolizable suspensions of proteins in ethanol |
| 05/25/2005 | EP1533294A1 Beta-alanine derivative and use thereof |
| 05/25/2005 | EP1532238A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 05/25/2005 | EP1532144A1 Novel quinuclidine derivatives and their use |
| 05/25/2005 | EP1532122A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 05/25/2005 | EP1532109A1 Pyrrolidine derivatives as oxytocin antagonists |
| 05/25/2005 | EP1531867A1 Metastable pharmaceutical compositions |
| 05/25/2005 | EP1531847A2 Pharmaceutical formulation |
| 05/25/2005 | EP1531838A2 Stem cells for treating pancreatic damage |
| 05/25/2005 | EP1531829A2 Infertility treatment with exemestane |
| 05/25/2005 | EP1531824A2 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders |
| 05/25/2005 | EP1531815A1 Glucokinase activators |
| 05/25/2005 | EP1531807A1 Bazedoxifene treatment regimens |
| 05/25/2005 | EP1531806A2 Use of thio-oxindole derivatives in treatment of hormone-related conditions |
| 05/25/2005 | EP1322286B1 Polymeric delivery formulations of leuprolide with improved efficacy |
| 05/25/2005 | EP1286673B1 Ligands of integrin receptors |
| 05/25/2005 | CN1620505A Pim-3 kinase as a target for type 2 diabetes mellitus |
| 05/25/2005 | CN1620461A 2-amino-propanol derivatives |
| 05/25/2005 | CN1620414A 维生素d类似物 Vitamin d analogues |
| 05/25/2005 | CN1620286A Compounds for blocking androgen receptors |
| 05/25/2005 | CN1202833C Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| 05/25/2005 | CN1202823C Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack |
| 05/25/2005 | CN1202821C Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (MIDDM) attack |
| 05/24/2005 | US6897319 Therapeutic drugs for treating central nervous system disorders |
| 05/24/2005 | US6897235 Compositions useful for the treatment of pathologies responding to the activation of PPAR-γ receptor |
| 05/19/2005 | WO2005044253A1 Phenylpropanoic derivatives and compositions containing same, which stimulate libido and the associated physiological mechanisms |
| 05/19/2005 | WO2004106934A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 05/19/2005 | US20050107428 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 05/19/2005 | US20050107416 17-hydroxy 4-aza androstan -3-ones as androgen receptor modulators |
| 05/19/2005 | US20050107390 i.e. 7-[(3R)-3-Amino-4-(3,4-difluorophenyl)butanoyl]-3-methyl-6-(phenylmethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine, dihydrochloride; antilipemic, antiobesity |
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | US20050107372 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/19/2005 | US20050107347 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 05/19/2005 | US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/19/2005 | US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders |
| 05/19/2005 | US20050106695 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 05/19/2005 | US20050106658 Remodeling and glycoconjugation of peptides |
| 05/19/2005 | US20050106266 docosahexaenoic acid and a calcium compound (carbonate, hydroxide,sulfate) |
| 05/19/2005 | CA2559017A1 Phenylpropanoic derivatives and compositions containing same, which stimulate libido and the associated physiological mechanisms |
| 05/19/2005 | CA2543489A1 Human anti il-15 antibody 146b7 inducing monocytes apoptosis, therapeutical uses thereof |
| 05/18/2005 | EP1530589A2 Fragments of proinsulin c-peptide |
| 05/18/2005 | EP1530573A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 05/18/2005 | EP1530565A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 05/18/2005 | EP1530483A2 T cell receptor cdr3 sequences and methods for detection |
| 05/18/2005 | EP1530476A1 Use of reboxetine for the treatment of hot flashes |
| 05/18/2005 | EP1530470A1 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 05/18/2005 | EP1530466A2 Use of lck inhibitor for treatment of immunologic diseases |
| 05/18/2005 | EP1436381B1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 05/18/2005 | EP1301184B1 Valproic acid and derivatives thereof as histone deacetylase inhibitors |
| 05/18/2005 | EP1263724B1 Novel compounds |
| 05/18/2005 | EP1224204B1 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 05/18/2005 | EP0830138B1 Use of fibroblast growth factor analogues to stimulate bone growth |
| 05/18/2005 | CN1617879A 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations |
| 05/18/2005 | CN1617859A 5-sulfanyl-4h-1, 2, 4-triazole derivatives and their use as a medicament |
| 05/18/2005 | CN1617737A Compositions and method for normalizing lipid levels in mammalian tissues |
| 05/18/2005 | CN1617703A Composition comprising at least one alkanolamide for inhibiting langerhans cells migration, and uses thereof |
| 05/18/2005 | CN1617691A Prevention and treatment of androgen-deprivation induced osteoporosis |